Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The correction states that the label change for Finasteride was in 2012, leading to more reports of side effects from non-healthcare people.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Some calcium supplements have more calcium than their labels say, and a few have less.

Researchers developed a new method to clearly see and label hair proteins with minimal errors using advanced freezing and microscopy techniques.

Minoxidil and finasteride are FDA-approved treatments for male hair loss, but off-label use of oral minoxidil, dutasteride, and higher doses of finasteride and minoxidil is increasing.

Many medications may be linked to cognitive disorders, but most lack warnings on labels.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Isotretinoin has many serious side effects, including some new ones, needing better safety measures and updated labels.

Botulinum toxin is effective for various skin conditions, but more research and awareness of side effects are needed.

The hair follicle bulge is an important area for adult stem cells involved in hair growth and repair, with potential for medical use needing more research.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Off-label treatments are heavily used for alopecia areata due to limited approved options.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

Abatacept may help some people with alopecia areata regrow hair.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Asthimajjapachak Churna is more effective than Shwadamshtradi Rasayana Churna for reducing hair fall.

The FDA approved using Cialis with Proscar for better treatment options.

A nonviral method was developed to label and culture human hair follicle stem cells.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Low-dose oral minoxidil may help with various hair loss types, but more research is needed.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

Flibanserin may help improve sexual symptoms in various conditions beyond its approved use.

Facia Men’s capsule effectively reduces hair loss in men safely.

Facia Men’s capsule effectively reduces hair loss in men safely.